EV-302: Exploratory analysis of nectin-4 expression and response to 1L enfortumab vedotin (EV) + pembrolizumab (P) in previously untreated locally advanced or metastatic urothelial cancer (la/mUC) Meeting Abstract


Authors: Powles, T. B.; van der Heijden, M. S.; Gupta, S.; Perez Valderrama, B.; Galsky, M. D.; Bedke, J.; Kikuchi, E.; Hoffman-Censits, J.; Maroto Rey, J. P.; Vulsteke, C.; Iyer, G.; Swami, U.; Shin, S. J.; Rodriguez-Vida, A.; Wozniak, M.; Homet Moreno, B.; Lu, J.; Yu, C.; Hogdal, L.; Loriot, Y.
Abstract Title: EV-302: Exploratory analysis of nectin-4 expression and response to 1L enfortumab vedotin (EV) + pembrolizumab (P) in previously untreated locally advanced or metastatic urothelial cancer (la/mUC)
Meeting Title: ESMO Congress 2024
Journal Title: Annals of Oncology
Volume: 35
Issue: Suppl. 2
Meeting Dates: 2024 Sep 13-17
Meeting Location: Barcelona, Spain
ISSN: 0923-7534
Publisher: Oxford University Press  
Date Published: 2024-09-01
Start Page: S1137
End Page: S1138
Language: English
ACCESSION: WOS:001326612902581
DOI: 10.1016/j.annonc.2024.08.2051
PROVIDER: wos
Notes: Meeting Abstract: 1966MO -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Gopakumar Vasudeva Iyer
    334 Iyer